# Pulmonology Referral

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Theodore Roosevelt (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI012-SYN
- Date: 2026-03-09
- Fictional facility: St. Posthumous Health Center
- Fictional author: Amos Kettering, MD
- Calendar frame: modern shifted

- To: Noor Haddad, MD, Pulmonology
- Urgency: Routine, within four weeks

## Referral question

Lifelong asthma in a 23-year-old athlete, uncontrolled on albuterol alone. Please confirm the diagnosis and severity, assess for type 2 inflammation and allergic triggers, and advise on treatment step and exercise. **S**

## Questions for the consultant

1. Do you agree that this is moderate persistent asthma, and is anything else, such as vocal cord dysfunction, contributing?
2. Is there evidence of type 2 or allergic inflammation, and which allergen measures are worthwhile?
3. Is Step 4 maintenance-and-reliever therapy the right level, and when should we step down?
4. How should he manage symptoms during boxing and rowing?
5. Is he a candidate for allergen immunotherapy or a biologic now or later?

## Pertinent history

Asthma since early childhood. For several months: symptoms most days, night waking about twice a week, and albuterol use most days; one oral corticosteroid course at urgent care in the winter. Asthma Control Test 13. Spirometry today: FEV1 3.20 L (72 percent predicted), FEV1/FVC 0.67, rising to 3.74 L after bronchodilator (17 percent, 540 mL). Never smoker; no occupational exposure; older carpeted apartment. Boxes, rows, and takes long hill walks. Albuterol was stopped today and budesonide-formoterol maintenance-and-reliever therapy started at two inhalations twice daily plus one as needed. **S**

- Theodore Roosevelt was born at 28 East 20th Street, New York City, on October 27, 1858. **D**
- In his autobiography Roosevelt wrote that he was a sickly, delicate boy who suffered much from asthma and frequently had to be taken away on trips to find a place where he could breathe; he remembered sitting up in bed gasping at night as a very small child. **D**
- When he was nearly fourteen, during an attack of asthma, he was sent alone to Moosehead Lake; after two other boys on the stage-coach easily overpowered him, he began boxing lessons and a long program of physical training, with his father's approval. **D**
- Roosevelt wrote that he was very near-sighted as a boy without knowing it, and that at about thirteen, after he could not read a distant billboard, he got his first pair of spectacles. **D**
- A 2015 review of the historical record in the Journal of Allergy and Clinical Immunology: In Practice concluded that his respiratory problems began in early childhood, that the record gives strong evidence for poorly controlled persistent asthma, that the asthma became relatively quiet in adolescence when his exercise program began at about 12, and that he continued to have serious exacerbations in adolescence and adulthood; it found little if any support for the claim that his asthma was psychosomatic. **R**
- Roosevelt received his Bachelor of Arts degree from Harvard in June 1880 and was elected to the New York State Assembly in 1881. **D**
- His father, Theodore Roosevelt Sr., died in 1878 shortly after being diagnosed with stomach cancer. **D**

2 later historical claims are omitted because they describe events after the index age. See the teaching note.

Baseline: FEV1 before bronchodilator: 3.2 L (low); FEV1 percent predicted: 72% (low); FVC: 4.8 L; FEV1/FVC ratio: 0.67 (low); FEV1 after bronchodilator: 3.74 L; Asthma Control Test: 13; PHQ-2: 0. All results are synthetic.

BP 118/72 mmHg; pulse 84 bpm; respirations 18/min; temperature 36.8 °C; oxygen saturation 96% on room air; weight 72 kg; BMI 23.5 kg/m². All vital signs are synthetic.

## Current medications

- Budesonide-formoterol 160/4.5 mcg inhaler, two inhalations twice daily for maintenance **S**
- Budesonide-formoterol 160/4.5 mcg inhaler, one inhalation as needed for symptoms and before exercise; no more than 12 inhalations a day in total **S**

## Plan so far

- Stop reliever-only albuterol and start budesonide-formoterol maintenance-and-reliever therapy at Step 4 (two inhalations twice daily plus one as needed, up to 12 a day), with a spacer and inhaler-technique teaching. Guideline: Global Strategy for Asthma Management and Prevention, 2025 update (2025); 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020) **S**
- Written asthma action plan with symptom and peak-flow zones (green 80 percent or more of personal best, yellow 50 to 79 percent, red below 50 percent), reviewed at every visit and after every exacerbation. Guideline: Global Strategy for Asthma Management and Prevention, 2025 update (2025); 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020); CMID: Clinical Monitoring Intelligence Database, asthma monograph (2026) **S**
- Asthma Control Test, inhaler technique, adherence, reliever use, triggers, and exacerbation history at every visit; review one to three months after starting controller therapy, then every three to twelve months, and within one week of any exacerbation; spirometry at diagnosis, three to six months after stabilization, then every one to two years. Guideline: Global Strategy for Asthma Management and Prevention, 2025 update (2025); 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020); CMID: Clinical Monitoring Intelligence Database, asthma monograph (2026) **S**
- Explain that exercise improves fitness but does not treat airway inflammation; take one reliever inhalation before boxing or rowing; use dust-mite-impermeable bedding covers once sensitization is shown. Guideline: Global Strategy for Asthma Management and Prevention, 2025 update (2025); 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020) **S**
- Yearly influenza vaccine, pneumococcal vaccination for chronic lung disease, and COVID-19 vaccination by CDC guidance. Guideline: CMID: Clinical Monitoring Intelligence Database, asthma monograph (2026); Summary of Risk-based Pneumococcal Vaccination Recommendations (2025) **S**
